Cargando…
MiR-148b-3p Regulates the Expression of DTYMK to Drive Hepatocellular Carcinoma Cell Proliferation and Metastasis
Deoxythymidilate kinase (DTYMK) has been identified as a putative oncogene associated with the incidence of hepatocellular carcinoma (HCC), but the mechanisms whereby it regulates this cancer type remain uncertain. The present study was therefore designed to explore the role of DTYMK in HCC and to e...
Autores principales: | He, Guifang, Qiu, Jing, Liu, Changchang, Tian, Ben, Cai, Duo, Liu, Shihai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8739515/ https://www.ncbi.nlm.nih.gov/pubmed/35004265 http://dx.doi.org/10.3389/fonc.2021.625566 |
Ejemplares similares
-
TRAIL promotes hepatocellular carcinoma apoptosis and inhibits proliferation and migration via interacting with IER3
por: Liu, Shihai, et al.
Publicado: (2021) -
TUG1 long non‐coding RNA enlists the USF1 transcription factor to overexpress ROMO1 leading to hepatocellular carcinoma growth and metastasis
por: Liu, Shihai, et al.
Publicado: (2020) -
LncRNA MALAT1 acts as a miR-125a-3p sponge to regulate FOXM1 expression and promote hepatocellular carcinoma progression
por: Liu, Shihai, et al.
Publicado: (2019) -
Dermatopontin inhibits WNT signaling pathway via CXXC finger protein 4 in hepatocellular carcinoma
por: Liu, Shihai, et al.
Publicado: (2020) -
DTYMK is essential for genome integrity and neuronal survival
por: Vanoevelen, Jo M., et al.
Publicado: (2021)